Life-threatening Escherichia coli cellulitis in patients with haematological malignancies

Journal of Medical Microbiology

Volumn 61, Issue PART 9, 2012, Pages 1324-1327

  Sunder, S ^a,b   Haguenoer, E ^a,b   Bouvet, D ^a,b   Lissandre, S ^a   Bree, A ^c   Perrotin, D ^a,b   Helloin, E ^c   Lanotte, P ^a,b   Schouler, C ^c   Guillon, A ^a,b  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UR1282   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AMIKACIN; AMINOGLYCOSIDE; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CD59 ANTIGEN; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; INVASIN; KETOPROFEN; LACTIC ACID; NORADRENALIN; PENEM DERIVATIVE; PROCALCITONIN; QUINOLONE; RITUXIMAB; VANCOMYCIN;

ADULT; AGED; ALLELE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ANURIA; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD PRESSURE MEASUREMENT; CANCER CHEMOTHERAPY; CASE REPORT; CELLULITIS; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOPENIA; ERYTHEMA; ESCHERICHIA COLI INFECTION; FEVER; GLASGOW COMA SCALE; HUMAN; IMMUNOCOMPROMISED PATIENT; LIMB SWELLING; MALE; METABOLIC ACIDOSIS; MULTIPLE MYELOMA; NEUTROPENIA; PAIN; PHYLOGENY; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPTIC SHOCK; SEROTYPE; SKIN BIOPSY; VITAL SIGN;

AGED; BACTEREMIA; CELLULITIS; CHRONIC DISEASE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOID; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SOFT TISSUE INFECTIONS; VIRULENCE FACTORS;

EID: 84865170738     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.042366-0     Document Type: Article

References (19)

1. Ananias, M. & Yano, T. (2008). Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41, 877-883.
2. Blanco, M., Blanco, J. E., Alonso, M. P. & Blanco, J. (1996). Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria. Eur J Epidemiol 12, 191-198.
3. Brzozowski, D. & Ross, D. C. (1997). Upper limb Escherichia coli cellulitis in the immunocompromised. J Hand Surg [Br] 22, 679-680.
4. CA-SFM (2010). Comite de l'antibiogramme de la Societe Francaise de Microbiologie. Recommandations 2010. Avalaible at www.sfmmicrobiologie. org.
5. Clermont, O., Bonacorsi, S. & Bingen, E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66, 4555-4558.
6. Croxen, M. A. & Finlay, B. B. (2010). Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8, 26-38.
7. Johnson, J. R., Delavari, P., Kuskowski, M. & Stell, A. L. (2001). Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 183, 78-88.
8. Johnson, J. R., Kuskowski, M. A., O'Bryan, T. T. & Maslow, J. N. (2002). Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J Infect Dis 185, 1439-1447.
9. Kang, C. I., Chung, D. R., Peck, K. R., Song, J. H. & Korean Network for Study of Infectious Diseases (2010). Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by Gram-negative bacilli. Ann Hematol 89, 1171-1173.
10. Lefort, A., Panhard, X., Clermont, O., Woerther, P. L., Branger, C., Mentré, F., Fantin, B., Wolff, M., Denamur, E. & COLIBAFI Group (2011). Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49, 777-783.
11. Moet, G. J., Jones, R. N., Biedenbach, D. J., Stilwell, M. G. & Fritsche, T. R. (2007). Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY antimicrobial surveillance program (1998-2004). Diagn Microbiol Infect Dis 57, 7-13.
12. Mora, A., López, C., Dabhi, G., Blanco, M., Blanco, J. E., Alonso, M. P., Herrera, A., Mamani, R., Bonacorsi, S. & other authors (2009). Extraintestinal pathogenic Escherichia coli O1:K1: H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution. BMC Microbiol 9, 132.
13. Petkovsek, Z., Elersic, K., Gubina, M., Zgur-Bertok, D. & Starcic Erjavec, M. (2009). Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol 47, 1811-1817.
14. Russo, T. A. & Johnson, J. R. (2000). Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181, 1753-1754.
15. Sleiman, J. N., D'Angelo, A. & Hammerschlag, M. R. (2007). Spontaneous Escherichia coli cellulitis in a child with nephrotic syndrome. Pediatr Infect Dis J 26, 266-267.
16. Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L. & other authors (2005). Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41, 1373-1406.
17. Vigil, K. J., Johnson, J. R., Johnston, B. D., Kontoyiannis, D. P., Mulanovich, V. E., Raad, I. I., Dupont, H. L. & Adachi, J. A. (2010). Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 50, 374-380.
18. Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. & other authors (2006). Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60, 1136-1151.
19. Yoon, T. Y., Jung, S. K. & Chang, S. H. (1998). Cellulitis due to Escherichia coli in three immunocompromised subjects. Br J Dermatol 139, 885-888.